http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3794737-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79751aeaa9923745648e5ae7d9c35782 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-46 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-46 |
| filingDate | 1972-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1974-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd75b0d3b4675e8c78ee1079756812d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_492189edc15acbf4f8f0903e3aa7b925 |
| publicationDate | 1974-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-3794737-A |
| titleOfInvention | P-(acetoaceta midoalkyl)benzenesulfonamide derivatives as hypoglycermicagents |
| abstract | Compounds of the class of 1-(p-(acetoacetamidoalkyl)phenylsulfonyl)-2-imino-imidazolidines and the pharmaceutically acceptable acid addition salts thereof, have hypoglycemic activity; the compounds are active ingredients of pharmaceutical compositions and can be used for the treatment of diabetes mellitus; a typical embodiment is 1-(p-(2-acetoacetamidoethyl)phenylsulfonyl)-2-imino-3-methyl-imidazolidine. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101311167-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4094235-A |
| priorityDate | 1969-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.